Cns Pharmaceuticals Inc (CNSP) Stock Price, Quote & News

Company Profile

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States. It develops TPI 287, an investigational chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma, metastatic breast cancer with brain metastases, non-small cell lung cancer, castration-resistant prostate cancer, and neuroblastoma; and Berubicin, an investigational anthracycline chemotherapy agent, which is...

Industry: Biotechnology

Sector: Healthcare

Phone: 800 946 9185

Website: cnspharma.com

Address:

2100 West Loop South, Suite 900, Houston, United States

NetworkNewsWire Aug. 27 at 5:10 PM

Covid-19 Vaccine Could Extend Survival of Brain Cancer Patients $CNSP #BioMed #Covid #Cancer https://ibn.fm/ACwVX

0 · Reply

VirtualInvestor Aug. 27 at 2:21 PM

$CNSP Participates in the Virtual Investor "Why Now" On-Demand Conference Hope starts with pursuing what's possible. https://vimeo.com/1221551759/6f89b281ba?fl=ml&fe=ec

0 · Reply

Cns_pharma Aug. 27 at 2:13 PM

$CNSP Participates in the Virtual Investor "Why Now" On-Demand Conference Access the webcast here: https://virtualinvestorco.com/why-now/ Press Release: https://cnspharma.com/cns-pharmaceuticals-participates-in-the-virtual-investor-why-now-on-demand-conference/

0 · Reply

NetworkNewsWire Aug. 24 at 7:54 PM

New T Cell Therapy Could Transform Glioblastoma Care $CNSP https://ibn.fm/02EqR #tinygems #stocks

0 · Reply

NetworkNewsWire Aug. 18 at 7:50 PM

Researchers Identify a Protein That Could Be Targeted in Glioblastoma Therapy $CNSP #BioMed #Protein #Glioblastoma https://ibn.fm/17Ztq

0 · Reply

VoidStrides Aug. 1 at 5:32 PM

W/L Monday: $RUBI main watch. $FCUV $APMD $SCYX $CNSP Going to be another hot week, good luck bulls.

0 · Reply

AC_TRADER Jul. 31 at 8:52 PM

$CNSP Levels made with @TrendSpider https://share.trendspider.com/chart/CNSP/75949f4i3w

0 · Reply

NetworkNewsWire Jul. 30 at 6:42 PM

Novel Vitamin B12 Treatment Offers Hope in Brain Cancer Treatment $CNSP https://ibn.fm/c0AUc #biomed #stocks

0 · Reply

NetworkNewsWire Jul. 27 at 6:54 PM

Experimental Immunotherapy Offers Hope Against Deadly Pediatric Brain Cancer $CNSP https://ibn.fm/IunaT #tinygems #stocks

0 · Reply

IronRod2 Jul. 24 at 4:49 PM

$CNSP $HIMS $FRMI $ZVRA $SLS CNSP BUY THE DIP. CNS Pharmaceuticals Breaking out imminent anytime now. Great Set up for explosive rally. Going all in for 10,000% gains. 🚀🚀CNSP🚀🚀🚀

0 · Reply

CNS Pharmaceuticals details business development strategy

Sep 1, 2026, 9:01 AM EDT - 1 hour ago

CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth

Aug 27, 2026, 9:01 AM EDT - 5 days ago

CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference

Aug 25, 2026, 8:00 AM EDT - 7 days ago

CNS Pharmaceuticals Proxy statement: Proxy filing

Aug 21, 2026, 8:00 AM EDT - 11 days ago

CNS Pharmaceuticals Proxy statement: Proxy filing

Aug 17, 2026, 8:00 AM EDT - 15 days ago

CNS Pharmaceuticals Slides: Investor presentation

2026-08-17T09:41:45.000Z - 15 days ago

CNS Pharmaceuticals reports Q2 EPS (37c) vs. ($6.42) last year

2026-08-17T09:40:51.000Z - 15 days ago

CNS Pharmaceuticals ‘actively evaluating’ business devlopment opportunities

2026-08-17T09:40:41.000Z - 15 days ago

CNS Pharmaceuticals sees cash runway ‘beyond’ twelve months

Aug 12, 2026, 8:00 AM EDT - 20 days ago

CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation

Aug 12, 2026, 7:00 AM EDT - 20 days ago

CNS Pharmaceuticals Quarterly report: Q2 2026

Aug 12, 2026, 7:00 AM EDT - 20 days ago

CNS Pharmaceuticals Earnings release: Q2 2026

Jun 8, 2026, 9:15 AM EDT - 3 months ago

CNS Pharmaceuticals CFO, Steve O'Loughlin, Highlights Company's Recent $22.5M Financing in Virtual Investor "What This Means" Segment

May 20, 2026, 9:02 AM EDT - 3 months ago

CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation Progress

2026-05-19T21:01:10.000Z - 3 months ago

CNS Pharmaceuticals files to sell 9.79M shares of common stock for holders

May 19, 2026, 8:00 AM EDT - 3 months ago

CNS Pharmaceuticals Registration statement: Registration filing

2026-05-14T16:25:17.000Z - 3 months ago

CNS Pharmaceuticals reports Q1 EPS ($7.30) vs. ($18.93) last year

2026-05-14T16:22:47.000Z - 3 months ago

CNS Pharmaceuticals sees cash runway ‘beyond’ twelve months

May 14, 2026, 8:00 AM EDT - 3 months ago

CNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress

May 14, 2026, 7:00 AM EDT - 3 months ago

CNS Pharmaceuticals Quarterly report: Q1 2026

May 14, 2026, 7:00 AM EDT - 3 months ago

CNS Pharmaceuticals Earnings release: Q1 2026

2026-05-05T16:22:32.000Z - 4 months ago

3 Penny Stocks to Watch Now, 5/5/26

ELPW PN

2026-05-04T13:58:45.000Z - 4 months ago

Why Is CNS Pharmaceuticals Stock (CNSP) Up Today?

2026-05-04T11:19:29.000Z - 4 months ago

CNS Pharmaceuticals prices 650,000 shares at $2.30 in private placement

May 4, 2026, 7:00 AM EDT - 4 months ago

CNS Pharmaceuticals Announces Oversubscribed $22.5 Million Private Placement Financing

Apr 22, 2026, 7:00 AM EDT - 4 months ago

CNS Pharmaceuticals Slides: Investor presentation

Mar 31, 2026, 7:00 AM EDT - 5 months ago

CNS Pharmaceuticals Annual report: Q4 2025

2026-03-11T12:52:04.000Z - 6 months ago

CNS Pharmaceuticals launches new corporate growth strategy

Mar 11, 2026, 8:35 AM EDT - 6 months ago

CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline

2026-03-02T13:42:54.000Z - 6 months ago

CNS Pharmaceuticals appoints Lynne Kelley as CMO

Mar 2, 2026, 8:25 AM EST - 6 months ago

CNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team

2026-02-17T13:45:41.000Z - 7 months ago

CNS Pharmaceuticals appoints Steven O’Loughlin as CFO, Dylan Wenke as CBO

Feb 17, 2026, 8:25 AM EST - 7 months ago

CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation

2026-01-27T14:15:45.000Z - 7 months ago

CNS Pharmaceuticals says priority ‘is to transform’ how company operates

Jan 27, 2026, 9:00 AM EST - 7 months ago

CNS Pharmaceuticals Issues Letter to Shareholders

2026-01-15T14:45:16.000Z - 8 months ago

CNS Pharmaceuticals Inc trading resumes

2026-01-15T14:35:44.000Z - 8 months ago

CNS Pharmaceuticals Inc trading halted, volatility trading pause

2025-12-17T12:15:58.000Z - 9 months ago

CNS Pharmaceuticals CEO John Climaco steps down, Rami Levin succeeds

Dec 17, 2025, 7:00 AM EST - 9 months ago

CNS Pharmaceuticals Announces CEO Transition

2025-11-17T14:01:48.000Z - 10 months ago

CNS Pharmaceuticals reports Q3 EPS ($5.76) vs. ($153.20) last year

2025-11-17T14:01:42.000Z - 10 months ago

CNS Pharmaceuticals sees cash runway into 2H26

Nov 17, 2025, 8:35 AM EST - 10 months ago

CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 14, 2025, 4:00 PM EST - 10 months ago

CNS Pharmaceuticals Quarterly report: Q3 2025

Nov 12, 2025, 7:00 AM EST - 10 months ago

CNS Pharmaceuticals Proxy statement: Proxy Filing

Nov 10, 2025, 8:45 AM EST - 10 months ago

CNS Pharmaceuticals Announces Acceptance of Three Abstracts for Poster Presentation at the Society of NueroOncology (SNO) 30th Annual Meeting

Oct 24, 2025, 8:00 AM EDT - 11 months ago

CNS Pharmaceuticals Proxy statement: Proxy Filing

Oct 10, 2025, 8:00 AM EDT - 11 months ago

CNS Pharmaceuticals Proxy statement: Proxy Filing

2025-09-12T13:05:32.000Z - 1 year ago

CNS Pharmaceuticals upgraded to Buy at Maxim on TPI-287 roadmap

Sep 8, 2025, 7:00 AM EDT - 1 year ago

CNS Pharmaceuticals Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 3, 2025, 9:15 AM EDT - 1 year ago

CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

NetworkNewsWire Aug. 27 at 5:10 PM

Covid-19 Vaccine Could Extend Survival of Brain Cancer Patients $CNSP #BioMed #Covid #Cancer https://ibn.fm/ACwVX

0 · Reply

VirtualInvestor Aug. 27 at 2:21 PM

$CNSP Participates in the Virtual Investor "Why Now" On-Demand Conference Hope starts with pursuing what's possible. https://vimeo.com/1221551759/6f89b281ba?fl=ml&fe=ec

0 · Reply

Cns_pharma Aug. 27 at 2:13 PM

0 · Reply

NetworkNewsWire Aug. 24 at 7:54 PM

New T Cell Therapy Could Transform Glioblastoma Care $CNSP https://ibn.fm/02EqR #tinygems #stocks

0 · Reply

NetworkNewsWire Aug. 18 at 7:50 PM

Researchers Identify a Protein That Could Be Targeted in Glioblastoma Therapy $CNSP #BioMed #Protein #Glioblastoma https://ibn.fm/17Ztq

0 · Reply

VoidStrides Aug. 1 at 5:32 PM

W/L Monday: $RUBI main watch. $FCUV $APMD $SCYX $CNSP Going to be another hot week, good luck bulls.

0 · Reply

AC_TRADER Jul. 31 at 8:52 PM

$CNSP Levels made with @TrendSpider https://share.trendspider.com/chart/CNSP/75949f4i3w

0 · Reply

NetworkNewsWire Jul. 30 at 6:42 PM

Novel Vitamin B12 Treatment Offers Hope in Brain Cancer Treatment $CNSP https://ibn.fm/c0AUc #biomed #stocks

0 · Reply

NetworkNewsWire Jul. 27 at 6:54 PM

Experimental Immunotherapy Offers Hope Against Deadly Pediatric Brain Cancer $CNSP https://ibn.fm/IunaT #tinygems #stocks

0 · Reply

IronRod2 Jul. 24 at 4:49 PM

$CNSP $HIMS $FRMI $ZVRA $SLS CNSP BUY THE DIP. CNS Pharmaceuticals Breaking out imminent anytime now. Great Set up for explosive rally. Going all in for 10,000% gains. 🚀🚀CNSP🚀🚀🚀

0 · Reply

IronRod2 Jul. 24 at 6:06 AM

$CNSP Stellar

0 · Reply

jake0T Jul. 24 at 5:55 AM

$CNSP $TNXP $ENSC $ISRG $HUMA Bullish Pendant Pattern. CNS-Pharmaceuticals CNSP is rebounding. 9700% next week Monday open. So this week Get on the CNS Pharmaceuticals CNSP moon rocket. FAST TRACK DESIGNATION + ORPHAN DRUG DESIGNATION + INTELLECTUAL PROPERTY COMMERCIALIZATION RIGHTS in E.U. & U.S.

0 · Reply

jake0T Jul. 24 at 5:55 AM

$CNSP $CDT $EDBL $DHR $TMO Bull Flag Price action. CNS-Pharmaceuticals CNSP is rebounding. Now get on the CNS Pharmaceuticals CNSP moon rocket 9700% on Monday open. FAST TRACK DESIGNATION + ORPHAN DRUG DESIGNATION + INTELLECTUAL PROPERTY COMMERCIALIZATION RIGHTS in E.U. & U.S.

0 · Reply

NetworkNewsWire Jul. 21 at 2:38 PM

Study Finds No Evidence That Mobile Phones Can Cause Brain Cancer $CNSP https://ibn.fm/wL5MZ #biomed #stocks

0 · Reply

IronRod2 Jul. 20 at 7:31 PM

$CNSP $ACHR $IREN $ PSKY $NUAI $WBD $CIFR $ONDS $ PATH $TSSI $QXO $CNSP CNS Pharmaceuticals is rebounding. Get on the CNS moon rocket.

0 · Reply

ClarityOfPurpose2 Jul. 20 at 7:08 PM

$CNSP The best things that they do are to figure out ways to stay in business, draw their salaries, and stay on Nasdaq. Especially regarding the continued Nasdaq listing.

1 · Reply

NetworkNewsWire Jul. 13 at 8:21 PM

Widely Prescribed Thyroid Hormone Could Prevent Pediatric Brain Tumor Recurrence $CNSP https://ibn.fm/GxmzX #tinygems #stocks TG 10am CNSP

0 · Reply

NetworkNewsWire Jul. 13 at 8:06 PM

Widely Prescribed Thyroid Hormone Could Prevent Pediatric Brain Tumor Recurrence $CNSP https://ibn.fm/GxmzX #tinygems #stocks

0 · Reply

NetworkNewsWire Jul. 13 at 8:01 PM

Widely Prescribed Thyroid Hormone Could Prevent Pediatric Brain Tumor Recurrence $CNSP https://ibn.fm/GxmzX #tinygems #stocks

0 · Reply

Oldbabe Jul. 13 at 7:27 PM

$CNSP Has CNSP stopped trading today? Has it finally died? Any news?

0 · Reply

Market Cap	8.07M
Revenue (ttm)	0.00
Net Income (ttm)	-15.85M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	5,000
Avg Vol	8,954
Day's Range	N/A - N/A
Shares Out	1.46M
Stochastic %K	72%
Beta	3.05
Analysts	Strong Sell
Price Target	$10.00